Hepatitis B is diagnosed with a simple blood draw that checks for specific proteins and antibodies related to the virus. No fasting or special preparation is needed. The CDC now recommends that all adults 18 and older get screened at least once in their lifetime, using a three-part blood test called the hepatitis B triple panel.
The Triple Panel: What the Standard Test Includes
The preferred screening test checks your blood for three markers at once. Each one tells a different part of the story: whether the virus is present, whether your body has fought it off, and whether you’ve ever been exposed at all.
- Hepatitis B surface antigen (HBsAg): This is a protein found on the outer surface of the virus itself. A positive result means the virus is actively present in your blood, either from a new or ongoing infection.
- Hepatitis B surface antibody (anti-HBs): This is a protective antibody your immune system produces in response to the virus or to vaccination. A positive result typically means you’re immune.
- Hepatitis B core antibody (anti-HBc): This antibody only develops after actual infection, not from vaccination. A positive result means you’ve been infected with hepatitis B at some point, even if the virus is no longer active.
Running all three tests together gives a complete picture. Older screening guidelines sometimes tested for only one or two markers, which could miss chronic infections or leave immunity status unclear. The updated CDC recommendation calls for the full triple panel specifically because it tells your provider what to do next, whether that’s vaccination, monitoring, or treatment.
What Your Results Mean
The combination of positive and negative results across the three markers determines your status. Here are the most common patterns:
If all three markers are negative, you’ve never been infected and you’re not immune. This means you’re a candidate for the hepatitis B vaccine.
If only the surface antibody (anti-HBs) is positive and the other two are negative, you’re immune from vaccination. Your body has the protective antibody it needs, and there’s no sign of past or current infection.
If the surface antigen (HBsAg) is positive along with the core antibody, but the surface antibody is negative, this pattern points to chronic hepatitis B. The virus is still active, your body hasn’t cleared it, and further evaluation is needed.
If the surface antigen is negative but both the core antibody and the surface antibody are positive, you’ve recovered from a past infection and are now immune. Your body successfully fought off the virus.
There’s also a gap called the “window period” that can complicate results. After a new infection, there’s a stretch of time when the surface antigen has already disappeared from your blood but the protective surface antibody hasn’t shown up yet. During this window, the core antibody may be the only detectable marker. If your provider suspects recent exposure, they may retest you a few weeks later to get a clearer picture.
When HBsAg Becomes Detectable
If you’re testing after a known or suspected exposure, timing matters. The surface antigen typically becomes detectable in the blood about 4 weeks after infection, though the range can be as early as 1 week or as late as 9 weeks. Testing too soon after exposure can produce a false negative. If your initial test is negative but you believe you were recently exposed, a follow-up test several weeks later is more reliable.
It’s also worth knowing that people who recently received the hepatitis B vaccine can temporarily test positive for the surface antigen, with reports of this happening up to 18 days after vaccination. If you test positive for HBsAg shortly after getting vaccinated, a repeat test at a later date can clarify whether the result reflects the vaccine or an actual infection.
Follow-Up Tests for Chronic Hepatitis B
If the triple panel reveals an active infection, additional testing helps determine how serious it is and whether treatment is needed. Two key follow-up measures are viral load and liver enzyme levels.
A viral load test (HBV DNA quantitative test) measures the actual amount of virus circulating in your blood. This is done through a specialized blood draw, and the results are reported in international units per milliliter. The test can detect viral levels across a wide range, from as low as 10 IU/mL up to 1 billion IU/mL. Higher viral loads generally indicate more active viral replication. This test is also used over time to track whether treatment is working.
Liver enzyme levels, particularly ALT (alanine aminotransferase), indicate whether the virus is causing inflammation in the liver. ALT is a normal enzyme, but when liver cells are damaged, they release more of it into the bloodstream. Levels more than twice the upper limit of normal, combined with a high viral load, generally indicate that treatment is needed. Levels that are elevated but below that threshold may call for ongoing monitoring or a liver biopsy to assess how much damage has occurred.
Who Should Get Tested
The CDC’s current recommendation is straightforward: every adult in the United States should be screened at least once. This is a significant expansion from earlier guidelines, which focused only on people in recognized risk groups. The shift reflects the reality that many people with chronic hepatitis B don’t know they’re infected, since the virus can persist for years without causing noticeable symptoms.
Beyond the one-time universal screen, periodic retesting is recommended for people with ongoing risk factors. This includes people who inject drugs, those with multiple sexual partners, household contacts of someone with hepatitis B, people born in regions where hepatitis B is common, and those receiving immunosuppressive therapy. Pregnant individuals are also tested during each pregnancy.
Testing for Infants Born to Infected Mothers
Babies born to a parent who tests positive for HBsAg receive their first dose of hepatitis B vaccine and a protective antibody injection at birth. After completing the full vaccine series, these infants are tested between 9 and 12 months of age (or 1 to 2 months after the final vaccine dose if the series was delayed). The infant panel checks for just two markers: HBsAg and anti-HBs. A negative surface antigen and a positive surface antibody confirm the child is both uninfected and protected. A negative surface antibody means the vaccine series didn’t produce adequate immunity, and additional doses may be needed.
Getting the Test
Hepatitis B testing is a standard blood draw from a vein in your arm. No fasting is required, and no special preparation is needed beforehand. Results typically come back within a few days. You can request the test through your primary care provider, a sexual health clinic, or a community health center. Many insurance plans cover hepatitis B screening as part of routine preventive care.
One practical note: high doses of biotin (a supplement sometimes taken for hair and nail growth) can interfere with the type of immune-based assays used in hepatitis B testing, potentially causing false results. If you take biotin supplements, mention it to your provider before testing.